Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
11/2003
11/20/2003WO2003095459A2 Alkaloid-derived compounds and use thereof in cancer and malaria treatment
11/20/2003WO2003095447A1 Process for the preparation of a hydrate of an anthranilic acid derivative
11/20/2003WO2003095427A1 Spiro-ring compound
11/20/2003WO2003057173A3 Broad spectrum inhibitors
11/20/2003WO2002102315A3 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
11/20/2003WO2002100860A3 Heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents
11/20/2003US20030216494 Free radical catalyst for addition polymer
11/20/2003US20030216421 Cascade esters of camptothecins and methods of treating cancer using these compounds
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent
11/20/2003US20030216378 Azepino[4,5-b]pyrano[3,2-e]indoles
11/20/2003US20030216373 Activity against both Gram-positive and Gram-negative pathogens are generally regarded as having a broad spectrum of activity
11/20/2003US20030216324 Five-member heterocyclic compounds substituted with an alpha-amino carbonyl group; antiasthma agents
11/20/2003US20030216260 Preparation by intramolecular cyclization
11/20/2003CA2484815A1 Cascade esters of camptothecins and methods of treating cancer using these compounds
11/19/2003EP1362052A1 Inhibitors of cruzipain and other cysteine proteases
11/19/2003EP1362051A2 Method for purifying 20(s)-camptothecin
11/19/2003EP1361877A1 Pharmaceutical dosage forms of epothilones for oral administration
11/19/2003EP0984970B1 Spiro-quinuclidine derivatives, their preparation and use
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0898571B1 Thieno-pyridine sulfonamides, derivatives thereof and related compounds that modulate the activity of endothelin
11/19/2003CN1457339A Chemokine receptor binding heterocyclic compounds
11/19/2003CN1456154A Method for curing sepsis
11/18/2003US6649763 Optically active quinoline carboxylic acid derivatives with 7-pyrrolidine substituents causing optical activity and a process for the preparation thereof
11/18/2003US6649647 Trioxane derivatives
11/18/2003US6649626 Stimulants of gamma -aminobutyric acid receptors; psychological disorders
11/18/2003US6649624 Useful as neuropeptide Y receptor antagonists and as agents for therapy of cardiovascular disorders, central nervous system disorders, metabolic diseases
11/18/2003US6649622 Treating diabetes, especially Type II diabetes
11/18/2003US6649618 Substituted amidoalkyl-uracils and their use
11/18/2003US6649608 Cyclin-dependent serine/threonine and focal adhesion kinase inhibitors
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/13/2003WO2003093274A1 Camptothecin-taxoid conjugates as antimitotic and antitumor agents
11/13/2003WO2003093252A1 Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase
11/13/2003WO2003093244A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003WO2003093231A2 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/13/2003WO2003092580A2 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003WO2003092374A2 Pesticidal heterocycles
11/13/2003WO2003032897A3 Azabicyclic compounds for the treatment of fibromyalgia syndrome
11/13/2003WO2003029213A9 Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002099077A3 Methods and compositions related to tagging of membrane surface proteins
11/13/2003US20030212271 Reacting dialkyl malonate ester with trifluoroacetic acid; cyclization, controlling temperature
11/13/2003US20030212115 Remedies for inflammatory bowel diseases
11/13/2003US20030212101 Respiratory system disorders; antiinflammatory agents; psychological disorders
11/13/2003US20030212094 Novel cyclic amide derivatives
11/13/2003US20030212089 Arylindenopyridines and related therapeutic and prophylactic methods
11/13/2003US20030212087 Plant extracts; antitumor, anticancer agents; topoisomerase inhibitor
11/13/2003CA2484599A1 Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
11/13/2003CA2484280A1 Substituted (thioxo)carbonylamino phenyl uraciles
11/13/2003CA2483843A1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
11/12/2003EP1361225A1 Compounds substituted with bicyclic amino groups
11/12/2003EP1359908A1 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
11/12/2003EP1280813B1 Anti-viral pyrimidine nucleoside analogues
11/12/2003EP1206265B1 Src kinase inhibitor compounds
11/12/2003EP1058549A4 THROMBIN OR FACTOR Xa INHIBITORS
11/12/2003EP0975599B1 Subtituted isoquinolines as ultra short acting neuromuscular blockers
11/11/2003US6645999 Lactacystin analogs
11/11/2003US6645990 For prophylaxis and therapy of diseases, such as cell proliferation or apoptosis mediated diseases
11/11/2003US6645983 Pharmaceutical compositions comprising 4-quinolones for treating cancers
11/11/2003US6645980 Ligands for biological receptors such as opiate receptors or G-protein coupled receptors used for treating pain, drug dependence or tinnitus in mammals
11/11/2003US6645975 Process for the preparation of dinaposoline
11/11/2003US6645973 Heterocyclic amines such as 1-carboxymethyl-4-(4-chlorophenyl) spiro(2H-1-benzopyran-2,4'-piperidine)hydrochloride used for therapy of nervous system disorders; Alzheimer's, Parkinson's and Huntington's disease
11/11/2003CA2290332C Optically pure androgen mediator
11/06/2003WO2003091264A2 Non nucleoside reverse transcriptase inhibitors
11/06/2003WO2003091257A1 [1,4]DIAZOCINO [7,8,1-hi]INDOLE DERIVATIVES AS ANTIPSYCHOTIC AND ANTIOBESITY AGENTS
11/06/2003WO2003091255A1 Inhibitors of checkpoint kinases (wee1 and chk1)
11/06/2003WO2003091253A1 Nitrosated imidazopyridines
11/06/2003WO2003090691A2 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003WO2003090690A2 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds and the compounds as such
11/06/2003WO2003090680A2 Novel phenyl derivatives as inducers of apoptosis
11/06/2003WO2003090672A2 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
11/06/2003WO2003039539A3 Use of endothelin receptor antagonists in the treatment of tumour diseases
11/06/2003WO2002076979A8 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin ii receptor antagonists
11/06/2003WO2002076375A3 Process for the preparation of benazepril
11/06/2003US20030208082 Nitrogen compounds such as 4,5-diisopropyl-1-methyl-2-styryl -1H-imidazole, used as glutamate receptor antagonists, for prophylaxis of psychological disorders, as anxiolytic agents and analgesics
11/06/2003US20030208076 Preparation of fused polycyclic alkaloids by ring closure of azomethine ylides, novel compounds thereof and their use as chemotherapeutic agents
11/06/2003US20030208066 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
11/06/2003US20030207900 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207883 Indazole benzimidazole compounds
11/06/2003US20030207824 Pyrimidine derivatives for labeled binding partners
11/06/2003CA2484090A1 Nitrosated imidazopyridines
11/06/2003CA2483496A1 Inhibitors of checkpoint kinases (wee1 and chk1)
11/06/2003CA2481449A1 Method and compositions for identifying anti-hiv therapeutic compounds
11/06/2003CA2481324A1 [1,4]diazocino [7,8,1-hi]indole derivatives as antipsychotic and antiobesity agents
11/06/2003CA2481285A1 Non nucleoside reverse transcriptase inhibitors
11/05/2003EP1359152A2 Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
11/05/2003EP1359146A2 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents
11/05/2003EP1359139A1 Terphenyl compounds bearing substituted amino groups
11/05/2003EP1358185A2 Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1220858B1 Oxazinoquinolones useful for the treatment of viral infections
11/05/2003EP0971930B1 Process for preparing single enantiomer narwedine
11/05/2003EP0946566B1 Pro-drugs and counterparts of camptothecin, their application as medicines
11/05/2003EP0861842B1 Novel water-soluble fluoroethylcamptothecin derivative and process for production thereof
11/05/2003CN1454083A Selective androgen receptor modulators and methods for their identification design and use
11/05/2003CN1453279A Plant extractive and alkaloid with cough-relieving activity
11/05/2003CN1126737C Novel pyrrole compound, its preparation and pharmaceutical composition containing the same
11/04/2003US6642249 3-Oxo-pyrazolo(4,3-c) -quinolin-2-yl, -thiochroman-2-yl, or -chromen-2-yl derivatives; CD80 antagonists
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 298